Related Experiment Video

Updated: Jun 1, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Overexpression and small molecule-triggered downregulation of CIP2A in lung cancer

Liang Ma1, Zhe-Sheng Wen, Zi Liu

  • 1Division of Molecular Carcinogenesis and Targeted Therapy for Cancer, State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.

Plos One
|June 10, 2011
PubMed
Abstract

Insights

Cancerous inhibitor of PP2A (CIP2A) is overexpressed in lung cancer, promoting cell growth. Targeting CIP2A with agents like rabdocoetsin B shows therapeutic potential for lung cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Lung cancer is a leading cause of cancer mortality globally, with poor survival rates.
  • Cancerous inhibitor of PP2A (CIP2A) is an oncoprotein implicated in various cancers, but its role in lung cancer is not well understood.

Purpose of the Study:

  • To investigate the expression of CIP2A in lung cancer.
  • To evaluate the therapeutic potential of targeting CIP2A in lung cancer cells.

Main Methods:

  • Analysis of CIP2A expression in lung tissues from 60 patients using RT-PCR, Western blotting, and immunohistochemistry.
  • In vitro studies involving siRNA-mediated silencing of CIP2A and treatment with rabdocoetsin B.

Main Results:

  • CIP2A was significantly overexpressed in 63.3% of lung tumor samples compared to adjacent normal tissues.
  • CIP2A overexpression correlated with cigarette smoking history.
  • Silencing CIP2A inhibited lung cancer cell proliferation and clonogenic activity.
  • Rabdocoetsin B downregulated CIP2A, inactivated the Akt pathway, inhibited proliferation, and induced apoptosis in lung cancer cells.

Conclusions:

  • CIP2A is a promising therapeutic target for lung cancer.
  • Further research into CIP2A-targeting agents is warranted for lung cancer drug development.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...